Radcliffe Capital Management’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

Radcliffe Capital Management’s Portfolio FRBN Stock Details FRBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-252,308	Closed	-$2.77M	–	450
2023 Q3	$2.77M	Sell	252,308 -123,766	-33%	-$1.34M	0.34%	105
2023 Q2	$4.04M	Sell	376,074 -24,806	-6%	-$263K	0.34%	100
2023 Q1	$4.22M	Buy	400,880 +27,006	+7%	+$281K	0.26%	120
2022 Q4	$3.86M	Buy	373,874 +118,363	+46%	+$1.21M	0.12%	264
2022 Q3	$2.58M	Hold	255,511	–	–	0.06%	522
2022 Q2	$2.56M	Buy	255,511 +820	+0.3%	+$8.18K	0.06%	543
2022 Q1	$2.54M	Buy	+254,691	New	+$2.53M	0.06%	523

Radcliffe Capital Management's FRBN Position: Q4 2023 in Review

Radcliffe Capital Management sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q4 2023, closing a stake of 252,308 shares — an estimated $2.77M sold.

Radcliffe Capital Management first reported a position in FRBN in Q1 2022 and held it in 7 quarters. The position peaked at $4.22M in Q1 2023. 0 funds tracked by Wall St. Rank hold FRBN as of Q4 2023.

Radcliffe Capital Management reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Radcliffe Capital Management sold 252,308 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $2.77M.
Radcliffe Capital Management first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
Radcliffe Capital Management's Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $4.22M in Q1 2023.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.